The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells

By sjmartinez • December 14, 2023

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2023 Dec 7:104900. doi: 10.1016/j.ebiom.2023.104900. Epub ahead of print. PMID: 38092579.

Tags: Cardiology/Epi, Harbor UCLA, Progenitor cell therapy, Publications, pulmonary arterial hypertension, Regenerative medicine, right ventricle, Short- and long-term safety

Low Prevalence of Coronary Artery Calcium in High Cardiometabolic Risk Kenyan Adults with and Without HIV: The ASANTE Study

Shah H, Krishnan S, Narashim A, Korir S, Omondi G, Maxime Ale B, Gitura BM, Kinuthia J, Farquhar C, Hsue PY, Budoff M, Longenecker CT,[...]

Significance of 3-dimensional cardiac anatomical axis as the predictor of low QRS amplitude of subcutaneous implantable cardioverter-defibrillator

Uehara Y, Ueda N, Mori S, Kawabata T, Ishibashi K, Oshima T, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada[...]

Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Budoff MJ, Ronda N. Sex and reproductive stage modify the effect of endogenous oestrogens on[...]